, Volume 19, Issue 1, pp 44–45 | Cite as

La Autoimmune Polyendocrine Syndrome type 1 (APS-1) o Multiple Autoimmune Syndrome type 1 (MAS-1)

  • Corrado Betterle


Conflitto di interesse

L’autore Corrado Betterle dichiara di non avere conflitti di interesse.


  1. 1.
    Betterle C, Presotto F (2008) Autoimmune Polyendocrine Syndromes (APS) or Multiple Autoimmune Syndromes (MAS). In: Walker S, Jara LJ (eds) Handbook of systemic autoimmune diseases, endocrine manifestations of systemic autoimmune diseases. Elsevier, Amsterdam, pp 135–148 CrossRefGoogle Scholar
  2. 2.
    Betterle C, Salvà M, Sabbadin C, Garelli S (2016) La Sindrome Poliendocrina Autoimmune di Tipo 1 in Italia. l’Endocrinologo 17:10–20 Google Scholar
  3. 3.
    Husebye ES, Perheentupa J, Rautemaa R, Kämpe O (2009) Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 265:514–529 CrossRefPubMedGoogle Scholar
  4. 4.
    Betterle C, Volpato M, Rees Smith B et al. (1997) II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison’s disease. J Clin Endocrinol Metab 82:939–942 PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Dipartimento di MedicinaUniversità di PadovaPadovaItalia

Personalised recommendations